Close Menu

NEW YORK – Genome Diagnostics, the Dutch molecular diagnostics company also known as GenDx, said this week that two of its next-generation sequencing products for human leukocyte antigen typing have received medical device licenses from Health Canada for in vitro diagnostic use.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.